Advertisement
Canada markets close in 1 hour 56 minutes

  • S&P/TSX

    22,313.49
    -62.34 (-0.28%)
     

  • S&P 500

    5,218.29
    +4.21 (+0.08%)
     

  • DOW

    39,462.67
    +74.91 (+0.19%)
     

  • CAD/USD

    0.7314
    +0.0003 (+0.04%)
     

  • CRUDE OIL

    78.29
    -0.97 (-1.22%)
     

  • Bitcoin CAD

    82,512.04
    -2,160.16 (-2.55%)
     

  • CMC Crypto 200

    1,253.27
    -104.74 (-7.71%)
     

  • GOLD FUTURES

    2,375.40
    +35.10 (+1.50%)
     

  • RUSSELL 2000

    2,056.09
    -17.54 (-0.85%)
     

  • 10-Yr Bond

    4.5000
    +0.0510 (+1.15%)
     

  • NASDAQ

    16,329.06
    -17.21 (-0.11%)
     

  • VOLATILITY

    12.73
    +0.04 (+0.32%)
     

  • FTSE

    8,433.76
    +52.41 (+0.63%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • CAD/EUR

    0.6788
    +0.0010 (+0.15%)
     
MARKETS LIVE BLOG:

STOCKS MIXED AS DOW EYES GAIN FOR 8TH STRAIGHT SESSION

Fed's Michelle Bowman echoes higher-for-longer mantra for interest rates

AIM ImmunoTech Reschedules Investor Conference Call to January 21, 2021 at 11AM ET

AIM ImmunoTech Inc.
·1 min read

AIM to discuss AMP-511 trial which includes COVID-19-induced chronic fatigue “long hauler” patients and other upcoming milestones

OCALA, Fla., Jan. 15, 2021 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) today announced that it has rescheduled its investor conference call for 11:00 a.m. Eastern Time on Thursday, January 21, 2021 to discuss the recently announced commencement of the treatment of subjects with COVID-19-induced chronic fatigue-like symptoms in the amended AMP-511 trial, recent accomplishments and upcoming milestones.

Investors and other interested parties are invited to submit questions to management prior to the call's start via email to aim@crescendo-ir.com. Management respectfully requests that questions be non-compound, direct and addressing single subjects.

The conference call will be available on the Company’s website at https://aimimmuno.com/events-presentations/, or via telephone by dialing toll free 877-407-8031 for U.S. callers, or +1 201-689-8031 for international callers.

ADVERTISEMENT

For those unable to participate at that time, a replay of the call will be archived on the Company’s website or can be accessed by dialing 877-481-4010 for U.S. callers, or +1 919-882-2331 for international callers and entering the pass code 39447. The replay will be available for 90 days.

About AIM ImmunoTech Inc.

AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.

Contacts:

Crescendo Communications, LLC
Phone: 212-671-1021
Email: aim@crescendo-ir.com

AIM ImmunoTech Inc.
Phone: 800-778-4042
Email: IR@aimimmuno.com